Increased Blood Plasminogen Activator Inhibitor-1 and Intercellular Adhesion Molecule-1 as Possible Risk Factors of Atherosclerosis in Werner Syndrome

Gerontology

Volumn 43, Issue , 1997, Pages 43-52

  Murano, Shunichi ^a   Nakazawa, Atsumi ^a   Saito, Ichiro ^a   Masuda, Mio ^a   Morisaki, Nobuhiro ^a   Akikusa, Bunshiro ^a   Tsuboyama, Tadao ^b   Saito, Yasushi ^a  

^a Chiba University   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Intercellular adhesion molecule 1; Plasminogen activator inhibitor 1; Vascular cell adhesion molecule 1; Werner syndrome

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ATHEROSCLEROSIS; AUTOPSY; BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPERLIPIDEMIA; MALE; PREMATURE AGING; PRIORITY JOURNAL; RISK FACTOR; SKIN FIBROBLAST; WERNER SYNDROME;

ADULT; AGED; AORTA, ABDOMINAL; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CELLS, CULTURED; CORONARY VESSELS; FEMALE; FIBROBLASTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; RNA, MESSENGER; SKIN; VASCULAR CELL ADHESION MOLECULE-1; WERNER SYNDROME;

EID: 0030913912     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213885     Document Type: Article

References (30)

1. Werner O: Uber Katarakt in Verbin-dung mil Sklerodennie: dissertation, Kiel University, 1904.
2. Epstein CJ, Martin GM, Schultz AL, Motulsky AG: Werer's syndrome: A review of its symptomatology, natural history, pathologic features, genetics and relationship to natural aging process, Medicine 1966:45:177-221.
3. Murano S: Potential for pharmacological intervention in Werner syndrome, Drugs Aging 1995:7:449-458.
4. Murano S, Thweatt R, Shmookler Reis RJ, Jones RA, Moerman EJ, Goldstein S: Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence, Mol Cell Biol 1991:11:3905-3914.
5. Ferran C, Millan MT, Cooper JT, Brostjan C, Bach FH, Winkler H: Inhibition of NF-kappa B by pyrrolidine dilhiocarbamate blocks endothelial cell activation, Biochem Bio-phys Res Comntun 1995:214:212-223.
6. Auffray C, Rougeon F: Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA, Eur J Biochem 1980:107:303-314.
7. Declerck PJ, Alessi MC, Verstrckcn M, Kruithof EK, Julian-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal an-tibodv-based enzyme-linked immunosorbent assay, Blood 1988:71: 220-225.
8. Ranbv M, Nguyen G, Scarabin PY, Santama M: Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes, Biochemical and mullicenter validation of a two-site immunosorbent assay, Thromb Haematost 1989:61:409-414.
9. Clauss A: Gerinnungsphysiologi-schc Schnellmethode zur Bestim-mung des Fibrinogens, Acta Haematol 1957:17:237-246.
10. Rothlein R, Mainolfi EA, Czajkow-ski M, Marlin SD: A form of circulating 1CAM-1 in human serum, J Immunol 1991:147:3788-3793.
11. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-I, and VCAM-1: Pathological significance, Ann NY Acad Sci 1992:667:324-331.
12. Kanzaki T, Murano S, Morisaki N, Saito Y, Yoshida S: Increased plasma fibronectin in Werner syndrome, Lancet 1992:339:1244-1245.
13. Saksela O, Rifkin DB: Cell-associated plasminogen activation: Regulation and physiological functions, Annu Rev Cell Biol 1988:4:93-126.
14. Goldstein S, Moerman EJ, Fujii S, Sobel BE: Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome, J Cell Physiol 1994:161: 571-579.
15. Schneidcrman J, Sawdcy MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries, Proc Natl Acad Sci USA 1992:89:6998-7002.
16. Hamsten A, Wiman B, DeFaire U, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction, N Engl J Med 1987:313:1557-1563.
17. Gram J, Jespersen J, Kluft C, Rijken DC: On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction, Acta Med Scand 1987.221: 149-153.
18. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EK: Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries, Arterioscler Thromb 1993;13:1090-1100.
19. Krishnamurti C, Tang DB, Barr CF, Alving BM: Plasminogen activator and plasminogen activator inhibitor activities in a reference population, Am J Clin Pathol 1988:89:747-752.
20. Conti P, Chiaramonte R, Maier JAM: Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells, Exp Cell Res 1995:219: 304-308.
21. Julian-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels, A possible link between insulin resistance and atherothrombosis, Diabetologia 1991:34:457-462.
22. Colwell JA: Vascular thrombosis in type II diabetes mcllitus, Diabetes 1993;42:8-11.
23. Nordt TK, Schneider DJ, Sobel BE: Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin, A potential risk factor for vascular disease, Circulat ion 1994:89:321-330.
24. Amman V, Stemme S, Rymo L, Ris-berg B: Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells, Thromb Res 1995;77:431-440.
25. Bevilacqua MP, Schleef RR, Gim-brone MA, Loskutoff DJ: Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986:78:587-591.
26. Printseva OY, Peclo MM, Gown AM: Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocyto-chemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992; 140: 889-896.
27. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques, Am J Pathol 1992; 140: 665-673.
28. Li H, Cybulsky ML Gimbrone MA, Libby P: An atherogenic diet rapidly induces VCAM-1. a cvtokine-regu-latable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium, Arteriosclcr Thromb 1993;13:197-204.
29. Fassbendcr K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M: Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke, Stroke 1995: 26:1361-1364.
30. En Yu C, Oshirna J, Fu Y-H, Wijs-man EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellen-berg GD: Positional cloning of the Werner’s syndrome gene, Science 1996;272:258-263.